Morris Ronnie

Average Profitability
86.37%
Insider Buys Quantity
16
Insider Buys Sum
$1.24M
Insider Sells Quantity
1
Insider Sells Sum
$393.75

Insider Activity of Morris Ronnie

The largest purchase of all time was on 2013-01-28 and amounted to 1000000 shares of Champions Oncology, Inc. for $500,000.

The largest sale of all time was on 2020-03-24 and amounted to 75 shares of Champions Oncology, Inc. for $394.

Biography of Morris Ronnie

No biography is available at this moment.

2023-03-17PurchaseChampions Oncology, Inc.
CSBR
CEO
12,382
0.0921%
$4.04$49,969+41.25%
2020-03-24SaleChampions Oncology, Inc.
CSBR
CEO
75
0.0006%
$5.25$394+65.16%
2020-03-20PurchaseChampions Oncology, Inc.
CSBR
CEO
75
0.0006%
$4.75$356+82.16%
2018-12-19PurchaseChampions Oncology, Inc.
CSBR
CEO
20,000
0.1757%
$7.44$148,800+7.4%
2018-03-27PurchaseChampions Oncology, Inc.
CSBR
CEO
2,300
0.0208%
$3.62$8,319+140.66%
2018-03-26PurchaseChampions Oncology, Inc.
CSBR
CEO
2,235
0.02%
$3.57$7,979+141.99%
2018-03-23PurchaseChampions Oncology, Inc.
CSBR
CEO
440
0.0039%
$3.50$1,540+142.36%
2018-03-22PurchaseChampions Oncology, Inc.
CSBR
CEO
460
0.0042%
$3.48$1,603+149.14%
2016-10-21PurchaseChampions Oncology, Inc.
CSBR
President
60,000
0.5611%
$1.67$100,300+76.69%
2016-10-19PurchaseChampions Oncology, Inc.
CSBR
President
20,000
0.1824%
$1.70$34,000+68.24%
2016-10-14PurchaseChampions Oncology, Inc.
CSBR
President
20,610
0.1891%
$1.66$34,213+72.73%
2016-10-13PurchaseChampions Oncology, Inc.
CSBR
President
59,390
0.5437%
$1.67$98,987+71.39%
2016-10-10PurchaseChampions Oncology, Inc.
CSBR
President
19,074
0.1739%
$1.66$31,663+70.48%
2016-09-20PurchaseChampions Oncology, Inc.
CSBR
President
6,000
0.0511%
$1.58$9,480+58.28%
2015-03-11PurchaseChampions Oncology, Inc.
CSBR
President
5.42M
$0$0+11.46%
2014-03-19PurchaseChampions Oncology, Inc.
CSBR
President
200,000
0.3047%
$1.07$213,980-32.38%
2013-01-28PurchaseChampions Oncology, Inc.
CSBR
President
1M
2.9926%
$0.50$500,000+202.86%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.